Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes

The measurable residual disease (MRD) assessment provides an attractive predictor of allogeneic hematopoietic cell transplnat (alloHCT) outcomes. Cell-free DNA (cfDNA) has been applied to diagnosis, early detection, and disease burden monitoring in various tumors, but its utility as an MRD test in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasca, Sergiu, Guo, Matthew Z., Wang, Shiyu, Stokvis, Kristin, Shedeck, Audra, Pallavajjala, Aparna, Shams, Cynthia, Pallavajjala, Roshni, DeZern, Amy E., Varadhan, Ravi, Gocke, Christopher D., Jones, Richard J., Gondek, Lukasz P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Hematopoiesis and Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448421/
https://www.ncbi.nlm.nih.gov/pubmed/37276081
http://dx.doi.org/10.1182/bloodadvances.2023010416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448421/
https://www.ncbi.nlm.nih.gov/pubmed/37276081
http://dx.doi.org/10.1182/bloodadvances.2023010416

Ejemplares similares